BMT CTN Protocol 0803

High Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients

Below are protocol-related documents, which may be periodically updated.

            Protocol Chair: Joseph Alvarnas, MD jalvarnas@coh.org

            Protocol Co-Chair: Richard Ambinder, MD (410-955-8839) ambinri@jhmi.edu

            Protocol Officer: Willis Navarro wnavarro@atarabio.com

            Protocol Coordinator: Samantha Wilkins (301-251-1161) swilkins@emmes.com

            Medical Monitor: Bipin Savani bipin.savani@vanderbilt.edu

                   

This study reached its target patient accrual on May 15, 2013 and is now closed to new enrollment.